Sanctuary Advisors LLC Acquires Shares of 35,901 Guardian Pharmacy Services, Inc. $GRDN

Sanctuary Advisors LLC acquired a new position in shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN) during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 35,901 shares of the company’s stock, valued at approximately $1,352,000.

Other institutional investors and hedge funds also recently modified their holdings of the company. Valiant Capital Management L.P. grew its stake in shares of Guardian Pharmacy Services by 15.8% in the fourth quarter. Valiant Capital Management L.P. now owns 1,232,463 shares of the company’s stock valued at $37,085,000 after buying an additional 167,741 shares in the last quarter. Wellington Management Group LLP lifted its position in Guardian Pharmacy Services by 3.3% during the 3rd quarter. Wellington Management Group LLP now owns 1,143,729 shares of the company’s stock worth $30,000,000 after acquiring an additional 36,072 shares in the last quarter. Franklin Resources Inc. lifted its position in Guardian Pharmacy Services by 8.2% during the 3rd quarter. Franklin Resources Inc. now owns 1,056,240 shares of the company’s stock worth $27,705,000 after acquiring an additional 80,033 shares in the last quarter. Vanguard Group Inc. boosted its holdings in Guardian Pharmacy Services by 9.1% in the 3rd quarter. Vanguard Group Inc. now owns 1,055,102 shares of the company’s stock worth $27,675,000 after acquiring an additional 88,296 shares during the period. Finally, Boston Partners boosted its holdings in Guardian Pharmacy Services by 0.7% in the 4th quarter. Boston Partners now owns 1,054,636 shares of the company’s stock worth $31,995,000 after acquiring an additional 7,759 shares during the period.

Guardian Pharmacy Services Stock Down 1.2%

GRDN stock opened at $39.29 on Friday. Guardian Pharmacy Services, Inc. has a 52-week low of $19.30 and a 52-week high of $44.00. The stock’s 50 day moving average is $40.28 and its two-hundred day moving average is $36.33. The company has a market capitalization of $1.96 billion, a PE ratio of 47.34, a P/E/G ratio of 2.61 and a beta of 0.05.

Guardian Pharmacy Services (NYSE:GRDN) last released its earnings results on Wednesday, May 6th. The company reported $0.29 EPS for the quarter, beating the consensus estimate of $0.24 by $0.05. Guardian Pharmacy Services had a return on equity of 30.72% and a net margin of 3.64%.The company had revenue of $336.60 million during the quarter, compared to analysts’ expectations of $329.89 million. During the same period in the prior year, the business posted $0.22 EPS. The business’s revenue was up 2.2% on a year-over-year basis. As a group, sell-side analysts anticipate that Guardian Pharmacy Services, Inc. will post 1.18 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on GRDN shares. Wall Street Zen lowered shares of Guardian Pharmacy Services from a “strong-buy” rating to a “buy” rating in a research note on Saturday, May 9th. Jefferies Financial Group began coverage on shares of Guardian Pharmacy Services in a report on Monday, March 30th. They set a “buy” rating and a $44.00 price target for the company. Weiss Ratings downgraded shares of Guardian Pharmacy Services from a “hold (c+)” rating to a “hold (c)” rating in a research note on Monday, May 11th. Bank of America boosted their price objective on shares of Guardian Pharmacy Services from $42.00 to $47.00 and gave the stock a “buy” rating in a report on Wednesday, June 17th. Finally, Oppenheimer upped their price objective on shares of Guardian Pharmacy Services from $38.00 to $43.00 and gave the company an “outperform” rating in a research report on Thursday, May 7th. Seven analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat, Guardian Pharmacy Services presently has an average rating of “Moderate Buy” and an average price target of $42.83.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.